Moderna improves forecast for 2022 sales from COVID-19 vaccine

Go back to Moderna improves forecast for 2022 sales from COVID-19 vaccine

Moderna (MRNA) Extends Gain, Now Up 11%

January 10, 2022 11:04 AM EST

Moderna (NASDAQ: MRNA) Extends Gain, Now Up 11%

... More

Moderna (MRNA) Trades at High, Up 2.8%

January 10, 2022 10:24 AM EST

Moderna (NASDAQ: MRNA) Trades at High, Up 2.8%

CEO Expects Omicron Booster to Enter Clinic in WeeksComments on Bloomberg TV... More